RNS Number : 1725E
Dukemount Capital PLC
26 October 2022
 

Dukemount Capital Plc

("Dukemount" or the "Company") Correction

On 20th October the Company announced that  Dukemount Capital Plc,  had  issued 128,132,190  ordinary  shares  following notice received  to convert a portion of the outstanding amount on the funding agreement dated 14 September 2021 (as amended on 10 October 2022 by a deed of variation) (the "Funding Agreement").

 

Application was  made to the Financial Conduct Authority ("FCA") for admission of the New Shares to the standard listing segment of the Official List and to the London Stock Exchange (the "LSE") for admission to trading of the New Shares on the LSE's Main Market for listed securities (together "Admission") with an  expected  Admission on or around 25 October 2022.

 

However, following further discussions with its advisers, and a clarification of the current Prospectus Rules, the application to admit the shares has been withdrawn. The shares could not be issued and admitted in full without a Prospectus.

 

Total Voting Rights

The Company does not hold any Ordinary Shares in treasury. Therefore  the total number of voting rights in Dukemount Capital plc remains as 588,110,974. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 (as in force in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018).

 

For further information, please visit www.dukemountcapitalplc.com or contact:

 

 

Dukemount Capital Plc


Geoffrey Dart / Paul Gazzard

Media Enquries

 

Miriad Media, Zak Mir

Tel: +44 (0)7867 527 659

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBKABBFBDKOKB